Nasal Mucormycosis: Our experience with 24 cases
Authors:
- 20 February 2020
- journal article
- research article
- Published by Index Copernicus in Otolaryngologia Polska
- Vol. 74 (4) , 37-40
Abstract
Background: Mucormycosis is a rare fungal infection affecting people with impaired immunity. The aim of this study is to shed light on the epidemiology, incidence, and outcome of patients with mucormycosis hospitalized at a tertiary care center in Pondicherry. Methods: We conducted a retrospective chart review between January 2008 and January 2018. All patients with proven or probable mucormycosis were included. Results: A total of 24 patients were included. Their median age was 49 years and the majority were males. Comorbidities included mainly hematologic malignancy and diabetes mellitus. A liposomal amphotericin B formulation alone or in combination with other antifungals was used as a first line agent in all patients. Conclusion: The incidence of mucormycosis has significantly increased over the past 10 years at our institution, most likely due to increased risk factors.Keywords
This publication has 3 references indexed in Scilit:
- Recent advances in the understanding and management of mucormycosisF1000Research, 2018
- Challenges in the diagnosis and treatment of mucormycosisMedical Mycology, 2018
- Mucormycosis in India: unique featuresMycoses, 2014